VP, Quality

Kyverna is seeking a Vice President, Global Head of Quality, to provide strategic leadership and executive oversight of all Quality functions across Kyverna’s global operations. This individual will be responsible for developing, implementing, and maintaining the GxP Quality framework (GCP, GLP, PV, GMP, GDP) supporting all Kyverna programs and ensuring the highest standards of quality, compliance, and patient safety throughout the organization. The VP will partner cross-functionally to define and embed a strong quality culture, align Quality initiatives with corporate strategy, and ensure operational excellence across the product lifecycle from clinical development through commercialization. The successful candidate will bring a forward-thinking, pragmatic approach to managing regulatory complexity and operational risk, ensuring sustained compliance while enabling innovation and growth. The ideal candidate will have a proven track record of leading global Quality organizations within the biopharmaceutical industry, with specific experience in autologous or allogeneic cell therapies. This role requires a seasoned leader who embodies Kyverna’s core values: Bring Intellectual Rigor, Elevate Each Other, and Stay True to Why.Title: VP, Global Head of QualityReporting to: Chief Technology OfficerLocation: Emeryville, CA (hybrid twice a week) or RemoteResponsibilities Build and Lead the Global Quality organization, ensuring proper and effective quality oversight and governance for all GxP disciplines across internal and external operations. Establish and uphold global quality standards for cell therapy programs, ensuring alignment with health authority requirements and industry best practicesEnsure product submissions, product performance, and compliance concerns are adjudicated in an effective way that is commensurate with prevailing and emerging regulatory expectations and in line with established Standards and Policies.  Serve as an integral member of Kyverna executive management, contributing to corporate and functional strategy. Building cross-functional relationships and representing the Quality function and quality standards on program and strategy teams. Ensure Quality is a strategic enabler of innovation, resource prioritization, effective risk management in line with the corporate phase of operations. Maintain expert, up-to-date knowledge of international GxP regulations and guidance. Serve as Kyverna’s primary point of contact with Health Authority inspectorates, leading global inspections, audits, and inspection-readiness initiativesDesign and implement robust, risk-based quality management systems and operations that ensure compliance across clinical trial execution, development, manufacturing, testing, and logistics operations. Develop escalation frameworks for timely and robust issue communication, management and resolutionProvide Quality oversight for international clinical trials, technical operations and external engagement, including due diligence, qualification, and ongoing management of Contract Manufacturing, Contract Research Organizations, and Strategic Partners. Ensure alignment with evolving regulatory expectations for cell and gene therapy productsProvide decisive leadership for significant compliance events, deviations, or product issues that could affect patient safety or business continuity, ensuring timely communication and effective mitigationProvide strategic leadership for Inspection Readiness including vendor selection and oversight, planning and training of all cross-function team members, and preparation for inspections including key vendors and investigator sites. Build, mentor, and empower a high-performing Quality team with clear accountability, efficient decision-making, and an unwavering commitment to excellencePartner closely with R&D, Manufacturing, Regulatory, and Commercial leaders to ensure cohesive implementation of Quality policies and timely resolution of quality-related mattersRepresent Kyverna in global industry forums, scientific boards, and regulatory working groups to influence and shape evolving standards in cell and gene therapy regulationQualificationsDegree in Life Sciences or equivalent discipline15+ years of experience in Biotech with at least 5 years leading the Quality function.  Prior experience with Cell Therapies is a must.Established track record of success supporting early and late stage CMC and clinical product development teams. Cell therapy product characterization, method bridging, comparability, control strategy experience is a plusProven track record of developing robust and agile Quality Processes and Practices for Development and Commercial operations. Proven track record overseeing complex inspection readiness programs and driving successful outcomes across multiple regulatory agency inspectionsStrong knowledge of applicable regulatory requirements, including FDA and EMA regulations and ICH guidelines, with an emphasis on requirements associated with the study of cells and tissues, particularly genetically modified cells as therapiesExcellent verbal, written and presentation skills to effectively communicate with all levels of managementExcellent leadership skills with the ability to influence and collaborate effectively across cross-functional teamsStrong analytical and problem-solving skills, with a focus on risk management and continuous improvementDemonstrated expertise in critical thinking, influence, negotiation, problem solving, strategic thinking and leadership in a matrix environmentDemonstrated strong leadership capability with ability to make and act on decisions while balancing speed, quality, and riskThe national salary range for this position is from $275,000 to $335,000 USD annually. This salary range is an estimate of what we reasonably expect to pay for this posted position, and the actual salary may vary based on various factors, including without limitation individual education, experience, tenure, skills and abilities, as well as internal equity and alignment with market data.  This position is also eligible for bonus, benefits, and participation in Company’s stock option plan.